| 000 | 05919cam a2200481Mi 4500 | ||
|---|---|---|---|
| 001 | 95247 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112654.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 170121s2017 sz ob 001 0 eng d | ||
| 020 |
_a3319337203 _q(electronic bk.) |
||
| 020 |
_a9783319337203 _q(electronic bk.) |
||
| 020 | _z331933719X | ||
| 020 |
_z9783319337197 _q(print) |
||
| 035 |
_a(OCoLC)969643378 _z(OCoLC)969852857 _z(OCoLC)973501622 _z(OCoLC)973741932 _z(OCoLC)973802280 _z(OCoLC)974651457 _z(OCoLC)981819643 _z(OCoLC)1005772071 _z(OCoLC)1011950304 |
||
| 040 |
_aEBLCP _cEBLCP _dN$T _dGW5XE _dYDX _dIDEBK _dUAB _dCOO _dOCLCQ _dDKU _dUPM _dOCLCO _dOCLCF _dIOG _dOCLCO _dMERER _dESU _dZ5A _dOCLCO _dJBG _dIAD _dOCLCO _dICW _dOCLCO _dICN _dOCLCQ _dOCLCO _dOTZ _dOCLCQ _dVT2 _dOCLCO _dOCLCQ _dJG0 _dOCLCO _dU3W _dOCLCO _dOCLCQ _dES-MaUEC _bspa |
||
| 050 | 4 |
_aQH588.S83 _bN487 2017 EB |
|
| 245 | 0 | 0 |
_aNeurological regeneration _cPhuc Van Pham, editor. |
| 264 | 1 |
_aCham _bSpringer _c2017 |
|
| 300 | _a1 recurso en línea (266 páginas) | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 | _aStem cells in clinical applications | |
| 500 | _a6.4 Mechanisms of€Action of€Mesenchymal Stromal Cell-ƯBased \Therapies in€Animal Models of€Neonatal Hypoxia-Ischemia. | ||
| 500 | _aIncluye índice | ||
| 500 |
_aSpringerLink _bSpringer Biomedical and Life Sciences eBooks 2017 English+International |
||
| 504 | _aIncluye referencias bibliográficas e índice | ||
| 505 | 0 | _aPreface; Contents; Biography; Chapter 1: Stem Cell Therapy in€Neurological and€Neurodegenerative Disease; 1.1 Introduction; 1.2 Types of€Stem Cells; 1.2.1 Embryonic Stem Cells; 1.2.2 Induced Pluripotent Stem Cells; 1.2.3 Tissue-Specific Stem Cells; 1.3 Stem Cell Therapy for€Neurological Diseases; 1.3.1 Alzheimer's Disease; 1.3.2 Parkinson's Disease; 1.3.3 Huntington's Disease; 1.3.4 Cancer; 1.4 Conclusion; References; Chapter 2: Stem Cell Therapy in€Traumatic Brain Injury; 2.1 Introduction; 2.2 Neuropathology of€Traumatic Brain Injury; 2.2.1 Primary Injury After Traumatic Brain Injury. | |
| 505 | 8 | _a2.2.2 Secondary Injury After Traumatic Brain Injury2.3 Current Pharmacotherapy for€Traumatic Brain Injury; 2.4 Stem Cell Therapy in€Traumatic Brain Injury; 2.4.1 Transplantation of€Exogenous Stem Cells in€Traumatic Brain Injury; 2.4.2 Stimulation of€Endogenous Neural Precursor Cells in€Traumatic Brain Injury; 2.5 Bench to€Bedside Translation of€Stem Cell Therapy in€Traumatic Brain Injury; 2.6 Conclusion; References; Chapter 3: Stem Cells in€Alzheimer's Disease Therapy; 3.1 Introduction; 3.2 Pathogenesis of€Alzheimer's Disease and€Drug Treatment; 3.3 Animal Models in€AD Therapy with€Stem Cells. | |
| 505 | 8 | _a3.4 Stem Cells as€a€Model to€Study AD3.5 The Use of€Stem Cells in€AD Therapy; 3.6 Conclusion; References; Chapter 4: Stem Cell-Based Approaches for€Treatment of€Glioblastoma; 4.1 Introduction; 4.2 Glioblastoma; 4.2.1 Epidemiology; 4.2.2 Genetic Background; 4.3 Current Treatment Options for€Glioblastoma; 4.3.1 Standard of€Care; 4.3.2 Molecular Treatment Strategies; 4.3.3 Limitations of€Available Treatments; 4.4 Application of€Stem Cells to€Glioblastoma Therapy; 4.4.1 Rationale for€Stem Cell-Based Therapies; 4.4.2 Application of€Stem Cells for€Treatment of€Glioblastoma; 4.4.3 Immunotoxins. | |
| 505 | 8 | _a4.4.4 Suicide Gene Fusion4.4.5 Oncolytic Viruses; 4.4.6 miRNAs; 4.5 Future Directions; 4.5.1 Limitations and€Potential Solutions; 4.5.2 Ethical Concerns; 4.5.3 Concluding Remarks; References; Chapter 5: Stem Cell-Based Therapies for€Parkinson's Disease; 5.1 Introduction; 5.2 Grafts of€Human Fetal Ventral Mesencephalic Tissue; 5.3 Stem Cell Properties and€Requirements for€Their Application in€CRT for€PD; 5.4 Multipotent Stem Cells; 5.4.1 Human Neural Stem Cells; 5.4.2 Human Mesenchymal Stem Cells; 5.4.3 Human Pluripotent Stem Cells; 5.4.4 Human Embryonic Stem Cells. | |
| 505 | 8 | _a5.4.5 Human Parthenogenetic Embryonic Stem Cells5.4.6 Human Induced Pluripotent Stem Cells; 5.5 Conclusions and€Future Directions; References; Chapter 6: Mesenchymal Stromal Cell Therapy for€Neonatal Hypoxic-Ischemic Encephalopathy; 6.1 Introduction; 6.2 Mesenchymal Stromal Cells; 6.3 The Therapeutic Efficacy of€Mesenchymal Stromal Cells in€Preclinical Animal Models of€Neonatal Hypoxia-Ischemia; 6.3.1 Mesenchymal Stromal Cells from€Adult Tissues; 6.3.2 Mesenchymal Stromal Cells from€Neonatal Tissues. | |
| 520 | 3 | _aThis invaluable resource explores the regenerative potential of stem cells in the nervous system, with a focus on clinical applications. The expertly authored chapters discuss cell-based therapies for spinal cord injury and regeneration, traumatic brain injury, glioblastoma, Parkinson's Disease, ischemic stroke, cell banking, human embryonic stem cells and related concerns, harvesting of adipose tissue, and more. These topics are contextualized within a discussion of future directions of these therapies. Neurological Regeneration, part of Springerℓ́ℓs Stem Cells in Clinical Applications series, is essential reading for scientists, researchers, advanced students and clinicians working in stem cells, neurology, regenerative medicine or tissue engineering. | |
| 650 | 7 |
_9143820 _aIngeniería biomédica _2fast _0(OCoLC)fst00832568 _0 |
|
| 650 | 7 |
_aMedicina regenerativa _0(OCoLC)fst01745494 _0 _2embne _9678347 |
|
| 700 | 1 |
_aPham, Phuc Van, _eeditor literario _993958 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-33720-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aEBOOK, asignarmaterias, EBSPRINGER_2017B | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95247 _d95247 _x1 |
||